- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01353170
Calcium Concentration in Bicarbonate Hemodialysis (HD)
May 11, 2011 updated by: Miulli General Hospital
Comparison Among Different Dialysate Calcium Concentrations in Bicarbonate Hemodialysis
The study was designed in order to investigate the effects of 3 different dialysate calcium concentrations may exert on mineral metabolism and hemodynamic stability in standard hemodialysis (hd).
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bari
-
Acquaviva delle Fonti, Bari, Italy, 70100
- Nephrology and dialysis unit Miulli General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- bicarbonate hd since 6 months
- uncomplicated hd sessions
Exclusion Criteria:
- Incident patients
- unstable hd patients
- patients aged less than 18 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prevalent hd patients
Patients undergoing three consecutive cross-over hd session with 3 different dialysate calcium concentrations
|
Calcium dialysate concentrations: 1.25, 1.35 and 1.5 mmol/l
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum calcium concentrations
Time Frame: 4 hours
|
Evaluation of calcium mass balances and ionized calcium serum concentrations profiling during three hd sessions with different calcium concentrations in the dialysate
|
4 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
September 1, 2010
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
May 9, 2011
First Submitted That Met QC Criteria
May 11, 2011
First Posted (Estimate)
May 12, 2011
Study Record Updates
Last Update Posted (Estimate)
May 12, 2011
Last Update Submitted That Met QC Criteria
May 11, 2011
Last Verified
December 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Basile calcium
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Calcium Mass Balances and Serum Calcium Profiling in hd Patients
-
Universidad Autonoma de San Luis PotosíUnknownCalcium , Prognosis in PatientsMexico
-
Ottawa Hospital Research InstituteRecruitingCalcium Supplementation in HIV Patients Using RaltegravirCanada
-
Sohag UniversityCompletedEffect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver PatientsEgypt
Clinical Trials on Dialysate calcium concentration
-
University Hospital, MontpellierRecruitingAcute Kidney Injury | Renal Replacement TherapyFrance
-
University of AarhusCompletedEnd Stage Renal Disease on DialysisDenmark
-
Brigham and Women's HospitalRecruitingIntradialytic Hypotension | Peri-dialytic Cardiac Rhythms | Electrolyte Changes | pH Changes | Adverse SymptomsUnited States
-
University of SydneyPeking University People's Hospital; Institute for Clinical Evaluative Sciences and other collaboratorsRecruitingEnd-Stage Kidney DiseaseAustralia, Canada, United Kingdom, Malaysia, Germany, India
-
Aristotle University Of ThessalonikiCompletedEnd Stage Kidney Disease | Intradialytic HypertensionGreece, Slovenia
-
VA Office of Research and DevelopmentCompletedEnd-stage Renal DiseaseUnited States
-
Beijing Friendship HospitalUnknown
-
University of Sao Paulo General HospitalCompletedEnd-stage Renal Disease | Myocardial StunningBrazil
-
University Medical Centre MariborCompleted
-
University of MichiganRenal Research InstituteCompletedChronic Kidney Disease | ArrhythmiaUnited States